Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Aromatase Inhibitors × Clear all

NCT02188745 2024-07-17

POLLY

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01446159 2020-06-02

Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

Phase 2 Completed

188 enrolled 32 charts

Breast Neoplasms, Neoplasm Metastasis